Peter Preston

787 total citations
18 papers, 343 citations indexed

About

Peter Preston is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Peter Preston has authored 18 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Peter Preston's work include Inhalation and Respiratory Drug Delivery (3 papers), Parathyroid Disorders and Treatments (3 papers) and Hormonal and reproductive studies (3 papers). Peter Preston is often cited by papers focused on Inhalation and Respiratory Drug Delivery (3 papers), Parathyroid Disorders and Treatments (3 papers) and Hormonal and reproductive studies (3 papers). Peter Preston collaborates with scholars based in United States, United Kingdom and Switzerland. Peter Preston's co-authors include James Carmichael, R F Willey, David Godden, Graham K. Crompton, Madeline H. Frame, Walter J. Curran, Shari Rudoler, Maria Werner‐Wasik, Benjamin W. Corn and Walter W. Hauck and has published in prestigious journals such as Gut, Biometrics and Journal of the American Geriatrics Society.

In The Last Decade

Peter Preston

18 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Preston United States 12 143 96 58 47 47 18 343
R. Windeck Germany 12 60 0.4× 60 0.6× 31 0.5× 188 4.0× 35 0.7× 34 476
S Zecca Italy 6 136 1.0× 72 0.8× 31 0.5× 11 0.2× 24 0.5× 6 412
D F Child United Kingdom 16 45 0.3× 43 0.4× 17 0.3× 26 0.6× 54 1.1× 23 627
E.E. Tucker United States 6 56 0.4× 57 0.6× 20 0.3× 18 0.4× 37 0.8× 6 632
A E Pekary United States 15 62 0.4× 51 0.5× 7 0.1× 24 0.5× 37 0.8× 16 864
Kazuwa Nakao Japan 8 67 0.5× 29 0.3× 15 0.3× 30 0.6× 27 0.6× 13 372
P. G. Walfish Canada 13 43 0.3× 43 0.4× 25 0.4× 24 0.5× 17 0.4× 22 545
Zeljko Dvanajscak United States 9 91 0.6× 40 0.4× 34 0.6× 237 5.0× 10 0.2× 11 366
Jonathan Beilin Australia 13 142 1.0× 39 0.4× 17 0.3× 17 0.4× 20 0.4× 17 655
Astrid Starke Switzerland 10 52 0.4× 26 0.3× 14 0.2× 96 2.0× 26 0.6× 12 411

Countries citing papers authored by Peter Preston

Since Specialization
Citations

This map shows the geographic impact of Peter Preston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Preston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Preston more than expected).

Fields of papers citing papers by Peter Preston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Preston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Preston. The network helps show where Peter Preston may publish in the future.

Co-authorship network of co-authors of Peter Preston

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Preston. A scholar is included among the top collaborators of Peter Preston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Preston. Peter Preston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Stephens‐Shields, Alisa J., John T. Farrar, Susan S. Ellenberg, et al.. (2020). Clinically Important Differences for Mobility Measures Derived from the Testosterone Trials. Journal of the American Geriatrics Society. 69(2). 517–523. 2 indexed citations
2.
Stephens‐Shields, Alisa J., Christina Wang, Peter Preston, Peter J. Snyder, & Ronald S. Swerdloff. (2019). Clinically Meaningful Change in Sexual Desire in the Psychosexual Daily Questionnaire in Older Men from the TTrials. The Journal of Sexual Medicine. 16(7). 951–953. 6 indexed citations
3.
Wang, Christina, Alisa J. Stephens‐Shields, Leonard R. Derogatis, et al.. (2018). Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials. The Journal of Sexual Medicine. 15(7). 997–1009. 12 indexed citations
4.
5.
Pierce, David M., Mary Corcoran, Patrick Martin, et al.. (2014). Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials. Drug Design Development and Therapy. 8. 529–529. 9 indexed citations
6.
Keith, Michael W., Rosamund Wilson, Peter Preston, & J. Brian Copley. (2014). Cost-Minimization Analysis of Lanthanum Carbonate Versus Sevelamer Hydrochloride in US Patients With End-stage Renal Disease. Clinical Therapeutics. 36(9). 1276–1286. 15 indexed citations
7.
Viswanathan, Girish, et al.. (2014). Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study. Thrombosis and Haemostasis. 112(7). 205–215. 2 indexed citations
8.
Wilson, Rosamund, Michael W. Keith, Peter Preston, & J. Brian Copley. (2013). The Real-World Dose-Relativity of Sevelamer Hydrochloride and Lanthanum Carbonate Monotherapy in Patients with End-Stage Renal Disease. Advances in Therapy. 30(12). 1100–1110. 11 indexed citations
9.
Corcoran, Mary E., et al.. (2013). Pharmacokinetics of Coadministered Guanfacine Extended Release and Lisdexamfetamine Dimesylate. Drugs in R&D. 13(2). 119–128. 15 indexed citations
10.
Werner‐Wasik, Maria, Shari Rudoler, Peter Preston, et al.. (1999). Immediate side effects of stereotactic radiotherapy and radiosurgery. International Journal of Radiation Oncology*Biology*Physics. 43(2). 299–304. 64 indexed citations
11.
Rudoler, Shari, Benjamin W. Corn, Maria Werner‐Wasik, et al.. (1998). Patterns of Tumor Progression After Radiotherapy for Low-Grade Gliomas. American Journal of Clinical Oncology. 21(1). 23–27. 32 indexed citations
12.
Hauck, Walter W., Peter Preston, & Frédéric Y. Bois. (1997). A group sequential approach to crossover trials for average bioequivalence. Journal of Biopharmaceutical Statistics. 7(1). 87–96. 13 indexed citations
13.
Smith, Woollcott, Andrew R. Solow, & Peter Preston. (1996). An Estimator of Species Overlap Using a Modified Beta-Binomial Model. Biometrics. 52(4). 1472–1472. 22 indexed citations
14.
Williford, Henry N., et al.. (1993). Iron Status in Women Aerobic Dance Instructors. International Journal of Sport Nutrition. 3(4). 387–397. 5 indexed citations
15.
Greenberg, Gordon R., A.M.J. Buchan, Robin S. McLeod, Peter Preston, & Z. Cohen. (1989). Gut hormone responses after reconstructive surgery for ulcerative colitis.. Gut. 30(12). 1721–1730. 12 indexed citations
16.
Willey, R F, David Godden, James Carmichael, et al.. (1982). Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma. British Journal of Diseases of the Chest. 76. 61–68. 42 indexed citations
17.
Willey, R F, David Godden, James Carmichael, et al.. (1982). Comparison of twice daily administration of a new corticosteroid budesonide with beclomethasone dipropionate four times daily in the treatment of chronic asthma.. PubMed. 76(1). 61–8. 48 indexed citations
18.
Carmichael, J. H. E., et al.. (1982). Twice daily inhalation of a new corticosteroid, budesonide, in the treatment of chronic asthma.. PubMed. 122. 138–42. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Windeck Breakdown of academic impact, for papers by S Zecca Breakdown of academic impact, for papers by D F Child Breakdown of academic impact, for papers by E.E. Tucker Breakdown of academic impact, for papers by A E Pekary Breakdown of academic impact, for papers by Kazuwa Nakao Breakdown of academic impact, for papers by P. G. Walfish Breakdown of academic impact, for papers by Zeljko Dvanajscak Breakdown of academic impact, for papers by Jonathan Beilin Breakdown of academic impact, for papers by Astrid Starke
Rankless by CCL
2026